MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
10 hedge funds and large institutions have $787K invested in MedAvail Holdings, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
5% less capital invested
Capital invested by funds: $827K → $787K (-$40K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$937 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
MDVL Hedge Fund Activity: Q3 2019 in Review
10 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q3 2019, worth a combined $787K — down 4.8% from $827K a quarter earlier.
Fund positioning in MDVL was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $937. The largest seller was Deutsche Bank, exiting entirely with an estimated $3K sold.
- 10 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $787K of MedAvail Holdings, Inc. Common Stock stock for Q3 2019, down 4.8% quarter-over-quarter.
- 1 fund opened new MedAvail Holdings, Inc. Common Stock positions in Q3 2019 and 1 closed out, a net change of 0 holders.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q3 2019 was UBS Group, an estimated $937 added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q3 2019 was Deutsche Bank, an estimated $3K sold.
Based on aggregated 13F filings for Q3 2019.